Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. has announced that its shareholders approved the subdivision of its equity shares through a postal ballot, with the results demonstrating a favorable outcome from the voting process. Each equity share with a face value of Rs. 5 will be split into five shares with a face value of Re. 1, also requiring an alteration to the company’s Memorandum of Association. The detailed voting report has been made publicly accessible on the company’s website.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
